Oral MS Agents: And Then There Were Two

Oral MS Agents: And Then There Were Two

A 58-year-old man named J.S. Cardiac screening with electrocardiography, stress echocardiography, or myocardial perfusion imaging: advice for high-value care from the American College of Physicians. Antibiotics kill bacteria, not viruses, and are of no use in treating a cold. Green from Brigham and Women’s Hospital and Harvard Medical School discusses key issues in implementing voluntary and state-mandated genomic sequencing for newborns. Henson: It’s very exciting. Several clinical assessment tools are available for assessment and documentation of the oral mucosa. The reasons for gender disparity become obvious when etiologies of ESRD in children are taken into account.

The potential for topical steroids to suppress the HPA in pediatric patients has been associated with treatment of patients with more severe disease who are 2 years of age or younger.[22-24] Prolonged use of topical corticosteroids around the eyes has been reported to induce open-angle glaucoma and cataracts,[25] although controlled studies have not been performed. Lawrence Parish: Well, I know when you say he is a wrestler, someone might raise the question, are these herpes simplex lesions? Read more about Herpes Simplex on Medscape. Extramammary Paget’s disease is a perianal glandular tumor that spreads along the epidermis and can eventually metastasize. Transfer from systemic therapy to mometasone may also unmask previously suppressed allergic or other immunologic conditions such as rhinitis, conjunctivitis, eosinophilic conditions, eczema, and arthritis. Studies suggest that efavirenz is primarily metabolized by the cytochrome P450 3A4 and cytochrome P450 2B6 isoenzymes. And at least the preliminary results that I’ve seen seem to indicate that there isn’t a significant risk for teratogenicity, although with animals there is some signal that there are birth defects associated with the drug.

Oral MS Agents: And Then There Were Two
Dr. 36(3):959-69. Report to your doctor any temperature greater than 102 F. Dr. Henson: Right. I think that they looked at the more than 2 million patient-years of experience with leflunomide over the past 10 years in the treatment of rheumatoid arthritis and used those data to come up with a black box warning for liver functions and for pregnancy. Variations exist among pediatric renal transplant centers regarding minimal age and size requirements considered necessary for successful renal transplantation, particularly if an adult living-donor transplant is being considered.

Because of their size, the calcineurin inhibitors are unlikely to penetrate intact skin to any significant extent. In addition, as in a previous case, I think treating the nasal area would also be important, because that is probably some of the etiology why it spread to the different areas. Primary infection. The principal manifestations of Behcet’s disease are aphthae, which can occur at any gastrointestinal site. In addition to moderate to severe photosensitivity, the agency has received postmarketing reports of phototoxicity reactions that can manifest as exaggerated sunburn reactions such as burning, erythema, exudation, vesicles, blistering, and edema that involve areas exposed to light (eg, the face, “V” area of the neck, extensor surfaces of the forearms, and dorsa of the hands). The main issue around fingolimod is the heart rate monitoring associated with the first dose; it is somewhat cumbersome for some centers to administer this drug because they don’t have the staff to monitor patients. This has made it somewhat difficult for patients to get on the drug.

The other thing is that if you stop the drug for more than 2 weeks, you need to be remonitored. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. A warm saltwater gargle can relieve a scratchy throat. Other effects to look out for are the development of macular edema with the first 3 months of dosage, liver function abnormalities like with most drugs, the concern around the development of herpes simplex viral infections (seen in the clinical trials), and making sure the patient has an immune response to chicken pox — 1 patient in the trial who previously hadn’t had chicken pox died from disseminated infection. With fingolimod we’re also trying to figure out what the long-term side-effect profile is. It’s been on the market now for 2 years — I can’t believe it’s already been 2 years! Some are graft-related (delayed graft function and ATN); and some are technical, such as vascular thrombosis, or anatomic, such as obstruction.

Chief among them are the severe lifestyle restrictions of having to travel to a treatment center multiple times per week. Jennifer Parish: Do you think we are going to run into the same problem we had in the past with the other topicals, where there is increasing resistance, and also a problem with contact dermatitis? Verrucae tend to be more keratinized with sharper projections than papillomas. Both drugs are effective, so I think that from that standpoint it makes sense to consider whether one drug vs the other makes more sense for our patients. The other thing associated with fingolimod is that, because of the bradycardia, we have to be careful that patients don’t have a history of heart rhythm abnormalities or take medications like beta-blockers or calcium channel blockers that could potentially cause arrhythmias. These drugs can be used for migraines, which occur frequently in patients with MS, so we need to be careful here.

You may also like